Search PubMed⌕ Search

Biomedical subjects

M J van Eenige

Publications and source records attributed to M J van Eenige.

At least 19 recordsLinked to original sources
PubMed2000

Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: quantitative comparison with (201)Thallium-SPECT and coronary angiography.

The clinical value of magnetic resonance perfusion imaging (MRI) was investigated by quantitative comparison with (201)thallium-single-photon emission computed tomography ((201)TI-SPECT) and quantitative coronary angiography (QCA). Short-axis imaging was performed during dipyridamole administration in 13 patients with single-vessel coronary artery disease. Using inner and outer contours, the myocardium was divided into 30 contiguous, radial regions. Defining a perfusion defect as a region with less than 90% of maximum (201)TI intensity, nine patients had a matching perfusion defect, two had no defect on both (201)TI-SPECT or MRI, and one had a defect on (201)TI-SPECT but not on MRI. One patient had a defect on both modalities but with inaccurate localization. Three perfusion parameters were investigated: a) maximum contrast enhancement (MCE); b) slope of the signal intensity versus time curve; and c) inverse mean transit time (1/MTT). The sensitivity and specificity of MCE in the detection of perfusion abnormalities with TI-SPECT as the reference method were 71% and 71%, respectively (slope 77% and 61%, 1/MTT 44% and 70%). Furthermore, correlations were calculated per patient for the entire circumference of the short-axis myocardium. Median correlations were as follows: MCE 0.92, slope 0.91, and 1/MTT 0.40. Mismatches between (201)TI defects and defects on MRI resulted in low mean correlations (MCE 0.45, slope 0.46, and 1/MTT 0.26). There was a trend between severity of perfusion defects on MRI (using MCE) and QCA stenosis area (r = -0.56, P = 0.06). Thus, MRI and (201)TI-SPECT demonstrate fair agreement in the assessment of perfusion defects but show moderate correlation when the entire short-axis myocardium is correlated.

Aged↗
PubMed2000

Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: implications for transmural assessment of myocardial perfusion.

The purpose of the study was to investigate the potential of magnetic resonance imaging (MRI) to assess transmural differences in myocardial perfusion. Contrast-enhanced MRI was performed at rest and during hyperemia in a dog model and in 22 patients with single-vessel coronary artery disease. From MR signal intensity-versus-time curves, three perfusion parameters were derived: maximum myocardial contrast enhancement (MCE), slope, and inverse mean transit time (1/MTT). In dogs, MCE correlated well (r = 0.87, p < 0.00001) with microsphere-assessed myocardial blood flow. In the patients, the subendocardial MCE decreased during hyperemia (0.89 +/- 0.18 vs. 0.74 +/- 0.15, p < 0.003) and was lower in subendocardium than in subepicardium (0.74 +/- 0.15 vs. 0.84 +/- 0.21, p < 0.02). Parameters slope and 1/MTT paralleled MCE. Contrast-enhanced MRI reflects the transmural redistribution of myocardial perfusion during hyperemia. Perfusion abnormalities can be identified most distinctly in subendocardial myocardium.

Adult↗
PubMed1997

Prognostic implications of restrictive left ventricular filling in acute myocardial infarction: a serial Doppler echocardiographic study.

OBJECTIVES: This study was designed to evaluate the relative prognostic significance of restrictive left ventricular (LV) filling after acute myocardial infarction. BACKGROUND: Data regarding the contribution of diastolic dysfunction to prognosis after myocardial infarction are limited, and the additional value over the assessment of systolic dysfunction is not known. METHODS: Serial Doppler echocardiography was performed in 95 patients on days 1, 3 and 7 and 3 months after acute myocardial infarction. Patients were classified into two groups: a restrictive group (n = 12) with a peak velocity of early diastolic filling wave (E)/peak velocity of late filling wave (A) ratio > or = 2 or between 1 and 2 and a deceleration time (DT) < or = 140 ms during at least one echocardiographic study; and a nonrestrictive group (n = 83) with an E/A ratio < or = 1 or between 1 and 2 and a DT > 140 ms at all examinations. RESULTS: Cardiac death occurred in 10 patients during a mean follow-up interval of 32 +/- 17 months. The survival rate at 1 year was 100% in the nonrestrictive group and only 50% in the restrictive group. After 1 year there was a continuing divergence of mortality, resulting in a 3-year survival rate of 100% and 22%, respectively. Univariate Cox analysis revealed that restrictive LV filling, wall motion score index, ejection fraction and end-systolic and end-diastolic volume indexes, as well as peak creatine kinase, peak MB fraction and heart failure during the hospital course were significant predictors of cardiac death, although restrictive filling was the single best predictor (p < 0.0001). Multivariate analysis showed that restrictive filling adds prognostic information to clinical and echocardiographic variables of systolic dysfunction. CONCLUSIONS: Restrictive LV filling after acute myocardial infarction is the single best predictor of cardiac death and adds significantly to clinical and echocardiographic markers of systolic dysfunction.

Case-Control Studies↗
PubMed1997

Heterogeneity of DMIPP uptake and its relationship with heterogeneous myocardial blood flow.

UNLABELLED: To assess its potential role as a new metabolic probe, the relationship between regional uptake of the 15-(p-[125I]-iodophenyl)-3,3-dimethylpentadecanoic acid (DMIPP) fatty acid analog and myocardial blood flow was studied. METHODS: In 14 open-chest dogs, the left anterior descending coronary artery was cannulated and extracorporal bypass-perfused at normal (control group; n = 4) and reduced flow (intervention group; n = 10). Myocardial blood flow (MBF) was assessed with 46Sc-labeled microspheres. Forty minutes after intravenous injection of DMIPP, the heart was excised and cut into 120 samples. In each sample, MBF ml x g(-1) x min(-1) and DMIPP uptake (percentage of the injected dose per gram, %ID/g) were assessed. RESULTS: In normal myocardium, MBF and DMIPP uptake were 1.10 +/- 0.18 ml x g(-1) x min(-1) and 1.18 +/- 0.42 x 10(-2) %ID/g, respectively. In the extracorporal bypass area, flow was reduced to 0.49 +/- 0.20 ml x g(-1) x min(-1) (p < 0.0001 compared to normal), and DMIPP uptake was decreased to 0.75 +/- 0.26 x 10(-2) %ID/g (p < 0.0001 compared to normal). DMIPP uptake and MBF positively correlated in normal (DMIPP uptake = 0.77 +/- 0.23 x MBF; r = 0.41; p < 0.0001) and hypoperfused (DMIPP uptake = 0.35 +/- 0.70 x MBF; r = 0.63; p < 0.0001) myocardium. The heterogeneity, indicated by the coefficient of variation, in normal myocardium was 0.23 +/- 0.05 for MBF and was lower (p < 0.0001) for DMIPP uptake: 0.13 +/- 0.05. During flow reduction, heterogeneity increased significantly (p < 0.0001) for both MBF (0.59 +/- 0.22) and DMIPP uptake (0.37 +/- 0.23). Also heterogeneity of the DMIPP uptake to MBF ratio, as an indicator of agreement, increased from 0.23 +/- 0.07 in normal to 0.46 +/- 0.19 in hypoperfused myocardium (p < 0.0001). CONCLUSION: DMIPP detects regionally hypoperfused myocardium, in which agreement between MBF and fatty acid uptake deteriorates. DMIPP uptake shows a different relationship with MBF in hypoperfused compared to normal myocardium. These observations suggest that DMIPP uptake may provide additional, unique information on regional myocardial ischemia.

Animals↗
PubMed1996

Value of magnetic resonance imaging in assessing patency and function of coronary artery bypass grafts. An angiographically controlled study.

BACKGROUND: Previous studies have demonstrated the high sensitivity and moderate specificity of standard magnetic resonance (MR) spin-echo (SE) and gradient-echo (GE) techniques in predicting the patency of coronary artery bypass grafts. These techniques, however, do not provide quantitative information. Therefore, the objectives of this study were first to investigate whether MR cine GE images, performed in addition to standard SE images, have additional value for the assessment of graft patency and second to assess the graft function by measuring the flow pattern and flow rate with MR phase velocity imaging. METHODS AND RESULTS: Forty-seven patients with previous histories of coronary artery bypass grafting underwent angiography and MR SE and cine GE phase velocity imaging. SE and GE images were evaluated by three independent observers blinded to the angiographic results. The spatial mean velocity and volume flow were measured and repeated for each image at consecutive 50-millisecond intervals throughout the cardiac cycle. The 47 patients had 98 proximal aortotomies, of which 60 were single and 38 sequential grafts. Seventy-three grafts were patent; 25 were occluded. Eighty-four grafts (86%) were eligible for comparison of the results of SE and GE images. Assessment of patency was inconclusive on SE images in 7 grafts (5 occluded by angiography) and on GE images in 7 grafts (2 occluded). A comparison of the results of contrast angiography and SE and GE MR imaging techniques showed that both techniques had a high sensitivity (both 98%) and somewhat lower specificity (85% and 88%, respectively) for graft patency. Combined analysis of the SE and GE images did not improve the accuracy. The strength of the interobserver agreement on GE images was good (kappa = 0.66), whereas on SE images the agreement was moderate (kappa = 0.51). Adequate MR phase velocity profiles were obtained in 62 (85%) of the 73 angiographically patent grafts. Graft flow was characterized by a balanced biphasic forward flow pattern. The volume flow of sequential grafts to 3 regions (136 +/- 106 mL/min) was significantly higher than in single grafts (63 +/- 41 mL/min, P < .01). CONCLUSIONS: Considering the good interobserver agreement and the 85% success rate of quantitative flow measurements, cine GE phase velocity mapping is a promising clinical tool in the noninvasive assessment of graft patency and function.

Aged↗
PubMed1995

Adverse long-term effects of reocclusion after coronary thrombolysis.

OBJECTIVES: This study sought to assess the long-term clinical consequences of reocclusion after coronary thrombolysis. BACKGROUND: After acute myocardial infarction successfully treated with thrombolysis, reocclusion occurs in approximately 30% of patients and leads to poorer in-hospital outcome. However, the long-term effects of reocclusion are unknown. METHODS: Three hundred patients with no history of coronary surgery and with a patent infarct-related artery at coronary angiography within 48 h after thrombolysis were enrolled in the Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis (APRICOT) trial. At a mean (+/- SD) of 77 +/- 23 days after thrombolysis, 248 patients (87%) underwent follow-up angiography. Reocclusion was observed in 71 (29%) of 248 patients. To compare outcome between 71 patients with and 177 without reocclusion an analysis of event-free survival, defined as a clinical course without death, reinfarction and revascularization, was performed. RESULTS: Over a 3-year follow-up period, event-free survival was significantly better in patients without reocclusion: At 1 year it was 63% for patients with and 83% for those without reocclusion (p < 0.001). In the first year, two or more cardiac-related events occurred in 24% of patients with and 6% of those without reocclusion (p < 0.001). Patients with reocclusion had a markedly higher reinfarction and revascularization rate. At 1 year the reinfarction rate was 23% for patients with and 5% for those without reocclusion (p < 0.001). CONCLUSIONS: This analysis shows the adverse influence of reocclusion on long-term clinical outcome in relation to reinfarction and need for revascularization. To further optimize prognosis after thrombolysis, prevention of reocclusion should become a main priority. Future research should focus on the criteria and timing of elective revascularization procedures in the prevention of coronary reocclusion.

Aged↗
PubMed1995

Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging.

The purpose of this study was to investigate the feasibility of first-pass MR imaging for measurement of regional myocardial blood flow in human beings. The first pass of the contrast agent Gd-DTPA through the myocardium was imaged in 12 normal volunteers with an ECG-gated Turbo-Flash sequence. The MTT of the contrast agent through the myocardium after a bolus injection was derived from curves of SI versus time. The bolus was injected through an intravenous catheter, which was advanced to the central venous position (preferably the right atrium). To investigate myocardial input function, different bolus concentrations and catheter positions were compared. It is concluded that first-pass MR imaging is feasible in human subjects when a central injection of 0.03 mmol/kg of Gd-DTPA is applied. MTT values were similar throughout the myocardium of normal subjects at rest, reflecting normal perfusion. Absolute values of MTT were related to the myocardial input.

Adult↗
PubMed1995

Magnetic resonance imaging of the pulmonary venous flow pattern in mitral regurgitation. Independence of the investigated vein.

OBJECTIVES: The aim of the present study was two-fold: first, to quantify characteristic parameters of the pulmonary venous flow pattern in patients with mitral regurgitation by using magnetic resonance phase velocity mapping; second, to determine whether this pattern is dependent on the vein being investigated and the direction of the regurgitant jet. BACKGROUND: Echocardiographic findings threw doubt on whether the pulmonary venous flow pattern is independent of the vein being investigated and whether the flow velocities in the pulmonary veins have a linear relationship with the volume flow. SUBJECTS AND METHODS: Flow patterns were assessed in all four pulmonary veins by magnetic resonance velocity mapping in healthy volunteers and in 17 patients with echocardiographically mild and 13 patients with severe regurgitation. RESULTS: No differences were found between the use of velocity or volume flow for characterizing individual curves. The pulmonary venous flow pattern in controls was characterized by six points, a biphasic systolic wave (maximum systolic volume flow: 29 +/- 18 ml.s-1), and end-systolic descent (24 +/- 18 ml.s-1), a biphasic diastolic wave (maximum diastolic volume flow: 69 +/- 22 ml.s-1) and an end-diastolic reversed flow. Reversed end-systolic flow was a characteristic sign of severe regurgitation (-10 +/- 18 ml.s-1). The systolic-to-diastolic flow ratio was lower in severe regurgitation (0.5 +/- 0.6) than in mild regurgitation (1.4 +/- 0.9), P < 0.0001). In severe regurgitation, the normalized time intervals from Q wave to the highest systolic peak and end-systolic descent were of less prolonged duration than in mild regurgitation and controls (P < 0.01). Flow patterns between veins were similar and the median of the correlation coefficients between the curves was the same in patients with or without an eccentric jet, 0.80 and 0.81, respectively. CONCLUSION: Magnetic resonance velocity mapping is helpful in determining and understanding pulmonary venous flow characteristics. It is demonstrated that the pulmonary venous flow pattern is independent of the vein being investigated irrespective of the regurgitant jet direction, and that it is useful in grading mitral regurgitation.

Adult↗
PubMed1994

Influence of pacing-induced myocardial ischemia on left atrial regurgitant jet: a transesophageal echocardiographic study.

OBJECTIVES: We investigated the influence of pacing-induced myocardial ischemia on systolic regurgitant jet in the left atrium, using simultaneous transesophageal echocardiography and transesophageal atrial pacing. BACKGROUND: In vitro studies have shown that ischemia-induced mitral regurgitation may occur as a result of mitral leaflet malcoaptation or (global) left ventricular dysfunction. However, no transesophageal echocardiographic study has thus far been performed to demonstrate the mechanism and extent of mitral regurgitation during myocardial ischemia in patients. METHODS: In 24 patients (mean [+/- SD] age 57 +/- 10 years) with (15 patients) and without (9 control subjects) coronary artery disease, heart rate, blood pressure and systolic regurgitant jet were assessed before and immediately after pacing. Pacing was increased stepwise up to 160 beats/min to provoke wall motion abnormalities while the left ventricular short axis was monitored at the midpapillary muscle level. Other variables obtained before and at peak pacing included left ventricular end-diastolic and end-systolic areas and left ventricular end-diastolic and end-systolic endocardial segmental lengths. RESULTS: Heart rate and blood pressure before and after pacing were not significantly different in control subjects or in patients. At baseline, a jet was present in all but three control subjects. New or increased anterior or posterior wall motion abnormalities were observed during pacing in seven and eight patients, respectively. End-systolic left ventricular areas and segment lengths were significantly reduced in control subjects compared with patients with coronary artery disease at peak pacing (p < 0.05). The increase in systolic regurgitant jet was significantly greater in patients (2.0 +/- 1.1 to 3.1 +/- 1.8 cm2 vs. 0.7 +/- 0.7 to 0.9 +/- 0.9 cm2 [after pacing], p < 0.01). This effect was greater in patients with posterior than with anterior wall motion abnormalities (3.5 +/- 1.6 vs. 2.1 +/- 1.2 cm2 [after pacing], p < 0.05). CONCLUSIONS: Quantitative changes in geometry and function of the left ventricle caused by pacing-induced myocardial ischemia augments systolic regurgitant jet size. An increase in the jet during atrial pacing is associated with new or increased wall motion abnormalities, especially of the posterior wall. Pacing-induced anterior wall motion abnormalities appear not to be related directly to an increase in the jet.

Blood Pressure↗
PubMed1994

Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling.

BACKGROUND: After successful thrombolysis for acute myocardial infarction, reocclusion is observed in about 30% of patients after 3 months and usually occurs without reinfarction. We studied the impact of reocclusion without reinfarction on global and regional left ventricular function and on remodeling during that period. METHODS AND RESULTS: The patients for this analysis constituted a subset of those enrolled in the APRICOT-trial, which was designed to study the efficacy of antithrombotics on the prevention of reocclusion. Patients were selected who had a left anterior descending- or right coronary artery-related myocardial infarction, had an angiographically patent infarct-related vessel when studied < 48 hours after intravenous thrombolysis, and underwent repeat cardiac catheterization at 3 months. Paired contrast ventriculograms of quality sufficient to analyze regional wall motion, global ejection fraction, and ventricular volumes were analyzed in 129 patients. Enzymatic infarct size and baseline left ventricular function as well as other baseline characteristics were similar in patients with (n = 34) and without (n = 95) reocclusion. Ejection fraction improved in anterior infarction without reocclusion from 47 +/- 10% to 54 +/- 13% (P = .0001) but not with reocclusion (baseline, 48 +/- 13%; 3 months, 48 +/- 16%). No improvement was seen in inferior infarction with or without reocclusion. Persistent patency allowed preservation of end-systolic volume index (ESVI) at 3 months (37 +/- 14 mL/m2) to baseline level (38 +/- 13 mL/m2), with a better chance for improvement of > 10 mL/m2 without reocclusion in those with baseline values > 40 mL/m2. After reocclusion, in contrast, ESVI increased from 37 +/- 14 to 43 +/- 20 mL/m2 (P = .08). Comparable mean changes of ESVI in response to persistent patency or reocclusion were seen in anterior versus inferior infarction. Recovery of infarct zone contractility was impaired by reocclusion, both in terms of abnormality of segment shortening and expressed in the number of segments showing abnormal wall motion. In anterior but not in inferior infarction, infarct zone contractility was better with good collaterals to the reoccluded artery compared with poor collaterals. CONCLUSIONS: After successful thrombolysis for acute myocardial infarction, reocclusion without reinfarction withholds salvaged myocardium from regaining contractility. This has deleterious consequences for regional and global left ventricular function and for remodeling. To further optimize prognosis in patients after thrombolysis, future research should focus on the prevention of reocclusion and should evaluate revascularization therapy in patients with reocclusion.

Collateral Circulation↗
PubMed1993

Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis.

OBJECTIVES: In the APRICOT study (Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis), we sought to determine whether angiographic characteristics of the culprit lesion could predict reocclusion after successful thrombolysis and to analyze the influence of three antithrombotic treatment regimens. BACKGROUND: After successful thrombolysis, reocclusion is a major problem. Prediction of reocclusion by angiographic data and choice of antithrombotic treatment would be important for clinical management. METHODS: After thrombolysis, patients were treated with intravenous heparin until initial angiography was performed within 48 h. Patients with a patent infarct-related artery were eligible. Three hundred patients were randomly selected for treatment with coumadin, aspirin (300 mg once daily) or placebo. Patency on a second angiographic study after 3 months was the primary end point of the study. RESULTS: Reocclusion rate was 25% with aspirin, 30% with coumadin and 32% with placebo (p = NS). Lesions with > 90% stenosis reoccluded more frequently (42%) than did those with < 90% stenosis (23%) (p < 0.01). Reocclusion rate of smooth lesions was higher (34%) than that of complex lesions (23%) (p < 0.05). In lesions with < 90% stenosis, the reocclusion rate was lower with aspirin (17%) than with coumadin (25%) or placebo (30%) (p < 0.01). In complex lesions, the reocclusion rate was lower with aspirin (14%) than with coumadin (32%) or placebo (25%) (p < 0.02). Multivariate analysis showed only stenosis severity > 90% to be an independent predictor of reocclusion (odds ratio 2.31, 95% confidence interval 1.28 to 4.18, p = 0.006). CONCLUSIONS: Angiographic features of the culprit lesion after successful coronary thrombolysis significantly predict the risk of reocclusion: high grade (> 90%) stenoses reoccluded more frequently. Aspirin was effective only in complex and less severe lesions (< 90% stenosis). These findings should prompt investigation of the effects of an aggressive approach to patients with severe residual stenosis.

Aspirin↗
PubMed1993

Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.

BACKGROUND: Successful coronary thrombolysis involves a risk for reocclusion that cannot be prevented by invasive strategies. Therefore, we studied the effects of three antithrombotic regimens on the angiographic and clinical courses after successful thrombolysis. METHODS AND RESULTS: Patients treated with intravenous thrombolytic therapy followed by intravenous heparin were eligible when a patent infarct-related artery was demonstrated at angiography < 48 hours. Three hundred patients were randomized to either 325 mg aspirin daily or placebo with discontinuation of heparin or to Coumadin with continuation of heparin until oral anticoagulation was established (international normalized ratio, 2.8-4.0). After 3 months, in which conservative treatment was intended, vessel patency and ventricular function were reassessed in 248 patients. Reocclusion rates were not significantly different: 25% (23 of 93) with aspirin, 30% (24 of 81) with Coumadin, and 32% (24 of 74) with placebo. Reinfarction was seen in 3% of patients on aspirin, in 8% on Coumadin, and in 11% on placebo (aspirin versus placebo, p < 0.025; other comparison, p = NS). Revascularization rate was 6% with aspirin, 13% with Coumadin, and 16% with placebo (aspirin versus placebo, p < 0.05; other comparisons, p = NS). Mortality was 2% and did not differ between groups. An event-free clinical course was seen in 93% with aspirin, in 82% with Coumadin, and in 76% with placebo (aspirin versus placebo, p < 0.001; aspirin versus Coumadin, p < 0.05). An event-free course without reocclusion was observed in 73% with aspirin, in 63% with Coumadin, and in 59% with placebo (p = NS). An increase of left ventricular ejection fraction was only found in the aspirin group (4.6%, p < 0.001). CONCLUSIONS: At 3 months after successful thrombolysis, reocclusion occurred in about 30% of patients, regardless of the use of antithrombotics. Compared with placebo, aspirin significantly reduces reinfarction rate and revascularization rate, improves event-free survival, and better preserves left ventricular function. The efficacy of Coumadin on these end points appears less than that of aspirin. The still-high reocclusion rate emphasizes the need for better antithrombotic therapy in these patients.

Aged↗
PubMed1991

Independent prognostic value of supraventricular arrhythmias on 24-h ambulatory monitoring following myocardial infarction.

To determine the prognostic value of supraventricular arrhythmias, in addition to ventricular arrhythmias and clinical variables after myocardial infarction, 99 consecutive patients had 24-h ambulatory monitoring within 2 weeks of discharge. All patients completed at least 4-year follow-up (mean 56 +/- 6 months). During follow-up there were 29 cardiac events (13 cardiac deaths and 16 reinfarctions). The highest risk was associated with ventricular tachycardia (positive predictive accuracy 100%, negative predictive accuracy 75%, risk ratio 4.0) and supraventricular tachycardia i.e. paroxysmal tachycardia or AV nodal tachycardia (positive predictive accuracy 86%, negative predictive accuracy 80%, risk ratio 4.2). By multivariate analysis, supraventricular tachycardia proved to be an independent predictive variable, in addition to ventricular tachycardia, premature ventricular depolarisations greater than or equal to 10 h-1 and the presence of Killip class greater than or equal to II while in the coronary care unit for future cardiac events. These data suggest that supraventricular tachycardias detected on 24-h ambulatory monitoring shortly after discharge carry a poor prognosis and may indicate a different pathophysiology as compared to ventricular tachycardias.

Aged↗
PubMed1991

Analysis of time-activity curves related to myocardial metabolism. The case of 123I-heptadecanoic acid.

Time-activity curves are frequently used in the external assessment of the kinetics of radiolabelled non-esterified fatty acids. Analysis of time-activity curves is accomplished by fitting an analytical curve through the data points of the time-activity curve, resulting in two or more parameters of the curve fit. Before interpreting the results of curve fitting, the precision of each of the parameters has to be determined. In the present study the precision of the parameters of monoexponential plus constant curve fit of time-activity curves after administration of 123I-heptadecanoic acid was assessed for an acquisition time of 75 min. Two parameters were used, the T1/2 of the monoexponential and the ratio A/A+C, where A is the amplitude of the monoexponential and C the constant. A model study was used to assess the precision of the parameters of curve fitting. The precision of the parameters was calculated for wide ranges of the T1/2 (0-60 min), A/A+C (0-100%) and the noise content of the time-activity curve. The results are presented as the 10th and 90th percentiles.

Animals↗
PubMed1990

Silent versus symptomatic myocardial ischemia during exercise testing: a comparison with coronary angiographic findings.

Two-hundred-and-eighty individuals with anginal complaints, without prior myocardial infarction and with a positive exercise stress test were divided into a group (n = 67) with exercise-induced silent myocardial ischemia and another group (n = 213) with exercise-induced angina pectoris. Both underwent coronary angiography and were compared with each other with respect to various exercise and angiographic parameters. Patients with exercise-induced silent ischemia attained a longer mean exercise duration (P less than 0.001), a higher peak exercise heart rate (P less than 0.0001) and a higher peak exercise rate pressure product (P less than 0.001) than patients with exercise-induced angina pectoris. In the latter group, more patients showed exercise-induced ST-segment depression greater than 2 mm (P less than 0.05). The group of patients with silent ischemia encompassed more individuals with normal coronary arteries (P less than 0.0001). More patients with exercise-induced angina pectoris had three-vessel disease (P less than 0.0001). The exclusion of patients with normal coronary arteries (23% in those with silent ischemia group and 6% in those with exercise-induced angina had no influence on the level of significance for peak heart rate, mean exercise duration and exercise duration greater than 10 min. Thus, in this population, exercise-induced silent myocardial ischemia is associated with better exercise performance and less extensive coronary arterial pathology than in exercise-induced angina pectoris.

Adult↗
PubMed1990

Clinical value of studies with radioiodinated heptadecanoic acid in patients with coronary artery disease.

The results described in the literature of myocardial scintigraphy with radioiodinated heptadecanoic acid (IHDA) to detect coronary stenoses are contradictory. In the present study, IHDA scintigraphy was performed in nine control subjects and 67 patients with coronary artery disease. The acquisition time was 75 min and background correction was not applied. The time-activity curves of regions of interest were analyzed by curve fitting with a monoexponential plus constant. Two parameters were used: the halftime value of the monoexponential (T1/2 in min) and the ratio of the amplitude (A) of the monoexponential and the total activity at time t = 0 (amplitude + constant = A + C): A/A + C as a percentage. Based on the control group, a region of normal T1/2 values and A/A + C ratios was defined, for each calculated T1/2-A/A + C pair the probability of originating from a normal region was calculated. The value of the IHDA test, using the index of merit (sensitivity + specificity-100%), increased in the patient group without MI with the severity of the stenosis (21%, 24% and 47% for stenoses greater than or equal to 75%, greater than or equal to 90% and greater than or equal to 99%). In patients with MI, only small positive values in regions of non-infarct-related vessels were found (-1%-16%). It is concluded that the value of the IHDA test to detect stenoses of coronary arteries is too low to apply this test in clinical practice. However, a new type of analysis is offered, based on curve fitting of individual pixels.(ABSTRACT TRUNCATED AT 250 WORDS)

Angina Pectoris↗
PubMed1990

The fate of 131I-17-iodoheptadecanoic acid during lactate loading: its oxidation is strongly inhibited in favor of its esterification. A radiochemical study in the canine heart.

The influence of lactate loading on fatty acid metabolism (pH = 7.4) by the normal canine heart was investigated radiochemically using the radioiodinated fatty acid 131I-17-iodoheptadecanoic acid (131I-17-HDA). Fatty acid metabolism was studied during control conditions (n = 8) and after lactate loading (n = 7). In the canine heart total myocardial 131I-17-HDA radioactivity (uptake) was not changed during the lactate intervention. The oxidation decreased fivefold (measured as free 131I-iodide ion) from 70% to 14% (p less than 0.0001, Student's t-test). Thin-layer chromatography of cardiac lipids demonstrated that the non-oxidized 131I-17-HDA was mainly stored in the triglycerides and phosphoglycerides. These results suggest that lactate inhibits cardiac 131I-HDA oxidation.

Animals↗